Last reviewed · How we verify
HBsAg vaccine with Entecavir — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HBsAg vaccine with Entecavir (HBsAg vaccine with Entecavir) — Genexine, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HBsAg vaccine with Entecavir TARGET | HBsAg vaccine with Entecavir | Genexine, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HBsAg vaccine with Entecavir CI watch — RSS
- HBsAg vaccine with Entecavir CI watch — Atom
- HBsAg vaccine with Entecavir CI watch — JSON
- HBsAg vaccine with Entecavir alone — RSS
Cite this brief
Drug Landscape (2026). HBsAg vaccine with Entecavir — Competitive Intelligence Brief. https://druglandscape.com/ci/hbsag-vaccine-with-entecavir. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab